It is highly expressed in both GC cells and tissues, and is linked to GC malignancy by stimulating EMT, migration and invasion, as well as inhibiting autophagy through positive regulation of the MEK1/ERK1/2 pathway. Here, MAP2K1 is linked to gastric cancer.